| EDC-2: the Endocrine Society's second scientific statement on endocrine-disrupting chemicals AC Gore, VA Chappell, SE Fenton, JA Flaws, A Nadal, GS Prins, ... Endocrine reviews 36 (6), E1-E150, 2015 | 2371 | 2015 |
| Per‐and polyfluoroalkyl substance toxicity and human health review: Current state of knowledge and strategies for informing future research SE Fenton, A Ducatman, A Boobis, JC DeWitt, C Lau, C Ng, JS Smith, ... Environmental toxicology and chemistry 40 (3), 606-630, 2021 | 1422 | 2021 |
| Targeted inactivation of the EGF and amphiregulin genes reveals distinct roles for EGF receptor ligands in mouse mammary gland development NC Luetteke, TH Qiu, SE Fssssenton, KL Troyer, RF Riedel, A Chang, ... Development 126 (12), 2739-2750, 1999 | 673 | 1999 |
| Executive summary to EDC-2: the Endocrine Society's second scientific statement on endocrine-disrupting chemicals AC Gore, VA Chappell, SE Fenton, JA Flaws, A Nadal, GS Prins, ... Endocrine reviews 36 (6), 593-602, 2015 | 672 | 2015 |
| Cancer and developmental exposure to endocrine disruptors. LS Birnbaum, SE Fenton Environmental health perspectives 111 (4), 389-394, 2003 | 638 | 2003 |
| Early life exposure to per-and polyfluoroalkyl substances (PFAS) and latent health outcomes: A review including the placenta as a target tissue and possible driver of peri-and … BE Blake, SE Fenton Toxicology 443, 152565, 2020 | 378 | 2020 |
| Endocrine-disrupting compounds and mammary gland development: early exposure and later life consequences SE Fenton Endocrinology 147 (6), s18-s24, 2006 | 369 | 2006 |
| Endocrine disrupting properties of perfluorooctanoic acid SS White, SE Fenton, EP Hines The Journal of steroid biochemistry and molecular biology 127 (1-2), 16-26, 2011 | 342 | 2011 |
| Phenotypic dichotomy following developmental exposure to perfluorooctanoic acid (PFOA) in female CD-1 mice: low doses induce elevated serum leptin and insulin, and overweight … EP Hines, SS White, JP Stanko, EA Gibbs-Flournoy, C Lau, SE Fenton Molecular and cellular endocrinology 304 (1-2), 97-105, 2009 | 324 | 2009 |
| Concentrations of phthalate metabolites in milk, urine, saliva, and serum of lactating North Carolina women EP Hines, AM Calafat, MJ Silva, P Mendola, SE Fenton Environmental health perspectives 117 (1), 86-92, 2009 | 274 | 2009 |
| Environmental exposures and mammary gland development: state of the science, public health implications, and research recommendations RA Rudel, SE Fenton, JM Ackerman, SY Euling, SL Makris Environmental health perspectives 119 (8), 1053-1061, 2011 | 255 | 2011 |
| Gestational PFOA exposure of mice is associated with altered mammary gland development in dams and female offspring SS White, AM Calafat, Z Kuklenyik, LT Villanueva, RD Zehr, L Helfant, ... Toxicological Sciences 96 (1), 133-144, 2007 | 242 | 2007 |
| Transforming growth factor alpha: expression, regulation, and biological activities DC Lee, SE Fenton, EA Berkowitz, MA Hissong Pharmacological Reviews 47 (1), 51-85, 1995 | 230 | 1995 |
| Developmental exposure to a commercial PBDE mixture, DE-71: neurobehavioral, hormonal, and reproductive effects PRS Kodavanti, CG Coburn, VC Moser, RC MacPhail, SE Fenton, ... Toxicological Sciences 116 (1), 297-312, 2010 | 217 | 2010 |
| Endocrine disruptors and the breast: early life effects and later life disease MB Macon, SE Fenton Journal of mammary gland biology and neoplasia 18, 43-61, 2013 | 215 | 2013 |
| Developmental toxicity of perfluorooctanoic acid in the CD-1 mouse after cross-foster and restricted gestational exposures CJ Wolf, SE Fenton, JE Schmid, AM Calafat, Z Kuklenyik, XA Bryant, ... Toxicological Sciences 95 (2), 462-473, 2007 | 201 | 2007 |
| Evaluation of maternal, embryo, and placental effects in CD-1 mice following gestational exposure to perfluorooctanoic acid (PFOA) or hexafluoropropylene oxide dimer acid (HFPO … BE Blake, HA Cope, SM Hall, RD Keys, BW Mahler, J McCord, B Scott, ... Environmental health perspectives 128 (2), 027006, 2020 | 200 | 2020 |
| Per-and poly-fluoroalkyl substances (PFAS) and female reproductive outcomes: PFAS elimination, endocrine-mediated effects, and disease BP Rickard, I Rizvi, SE Fenton Toxicology 465, 153031, 2022 | 197 | 2022 |
| Associations between longitudinal serum perfluoroalkyl substance (PFAS) levels and measures of thyroid hormone, kidney function, and body mass index in the Fernald Community Cohort BE Blake, SM Pinney, EP Hines, SE Fenton, KK Ferguson Environmental pollution 242, 894-904, 2018 | 197 | 2018 |
| Persistent Abnormalities in the Rat Mammary Gland following Gestational and Lactational Exposure to 2,3,7,8-Tetrachlorodibenzo-p-dioxin (TCDD) SE Fenton, JT Hamm, LS Birnbaum, GL Youngblood Toxicological sciences 67 (1), 63-74, 2002 | 195 | 2002 |
